CA2336592A1 - Cell lines for the propagation of mutated herpes viruses - Google Patents
Cell lines for the propagation of mutated herpes viruses Download PDFInfo
- Publication number
- CA2336592A1 CA2336592A1 CA002336592A CA2336592A CA2336592A1 CA 2336592 A1 CA2336592 A1 CA 2336592A1 CA 002336592 A CA002336592 A CA 002336592A CA 2336592 A CA2336592 A CA 2336592A CA 2336592 A1 CA2336592 A1 CA 2336592A1
- Authority
- CA
- Canada
- Prior art keywords
- hsv
- gene
- cell line
- herpes virus
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16641—Use of virus, viral particle or viral elements as a vector
- C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9816856.0A GB9816856D0 (en) | 1998-08-03 | 1998-08-03 | Cell lines for virus growth |
GB9816856.0 | 1998-08-03 | ||
PCT/GB1999/002547 WO2000008194A2 (en) | 1998-08-03 | 1999-08-03 | Cell lines for the propagation of mutated herpes viruses |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2336592A1 true CA2336592A1 (en) | 2000-02-17 |
Family
ID=10836609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002336592A Abandoned CA2336592A1 (en) | 1998-08-03 | 1999-08-03 | Cell lines for the propagation of mutated herpes viruses |
Country Status (14)
Country | Link |
---|---|
US (1) | US7262033B1 (xx) |
EP (1) | EP1102858B1 (xx) |
JP (1) | JP2002526039A (xx) |
KR (1) | KR20010072236A (xx) |
CN (1) | CN1187453C (xx) |
AT (1) | ATE279526T1 (xx) |
AU (1) | AU766267B2 (xx) |
BR (1) | BR9912719A (xx) |
CA (1) | CA2336592A1 (xx) |
DE (1) | DE69921148T2 (xx) |
GB (2) | GB9816856D0 (xx) |
HK (1) | HK1037213A1 (xx) |
IL (1) | IL141127A0 (xx) |
WO (1) | WO2000008194A2 (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60141976D1 (de) | 2000-11-29 | 2010-06-10 | Univ Rochester | Helfervirus-freie herpesvirus-amplifikatpartikel und deren verwendungen |
US8092791B2 (en) | 2001-05-23 | 2012-01-10 | University Of Rochester | Method of producing herpes simplex virus amplicons, resulting amplicons, and their use |
WO2004064765A2 (en) * | 2003-01-23 | 2004-08-05 | University Of Rochester | Herpesvirus amplicon particles |
GB0317511D0 (en) | 2003-07-25 | 2003-08-27 | Biovex Ltd | Viral vectors |
AU2005302408B2 (en) | 2004-10-28 | 2012-08-09 | The Government of the United States of America as represented by the Department of Veterans Affairs | Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain |
US11299715B2 (en) | 2013-01-08 | 2022-04-12 | Genzyme Corporation | Use of iNOS inhibitors to increase viral yield in culture |
WO2022170219A1 (en) | 2021-02-05 | 2022-08-11 | Iovance Biotherapeutics, Inc. | Adjuvant therapy for cancer |
CN114107230B (zh) * | 2021-11-29 | 2023-08-11 | 东北农业大学 | 一种牛疱疹病毒1型ul41缺失毒株及其获取方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5804413A (en) * | 1992-07-31 | 1998-09-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
GB9415369D0 (en) | 1994-07-29 | 1994-09-21 | Lynxvale Ltd | Mutant virus |
US6200811B1 (en) * | 1996-04-02 | 2001-03-13 | The Regents Of The University Of California | Cell transformation vector comprising an HIV-2 packaging site nucleic acid and an HIV-1 GAG protein |
GB9615794D0 (en) * | 1996-07-26 | 1996-09-04 | Medical Res Council | Mutant herpes simplex virus strains and uses thereof |
-
1998
- 1998-08-03 GB GBGB9816856.0A patent/GB9816856D0/en not_active Ceased
-
1999
- 1999-08-03 IL IL14112799A patent/IL141127A0/xx unknown
- 1999-08-03 WO PCT/GB1999/002547 patent/WO2000008194A2/en not_active Application Discontinuation
- 1999-08-03 KR KR1020017001486A patent/KR20010072236A/ko not_active Application Discontinuation
- 1999-08-03 CN CNB998116734A patent/CN1187453C/zh not_active Expired - Fee Related
- 1999-08-03 AT AT99936864T patent/ATE279526T1/de not_active IP Right Cessation
- 1999-08-03 US US09/762,098 patent/US7262033B1/en not_active Expired - Lifetime
- 1999-08-03 JP JP2000563817A patent/JP2002526039A/ja active Pending
- 1999-08-03 GB GB0104403A patent/GB2361243B/en not_active Expired - Lifetime
- 1999-08-03 CA CA002336592A patent/CA2336592A1/en not_active Abandoned
- 1999-08-03 EP EP99936864A patent/EP1102858B1/en not_active Expired - Lifetime
- 1999-08-03 DE DE69921148T patent/DE69921148T2/de not_active Expired - Lifetime
- 1999-08-03 AU AU51837/99A patent/AU766267B2/en not_active Ceased
- 1999-08-03 BR BR9912719-9A patent/BR9912719A/pt not_active Application Discontinuation
-
2001
- 2001-11-05 HK HK01107706A patent/HK1037213A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1037213A1 (en) | 2002-02-01 |
DE69921148D1 (de) | 2004-11-18 |
GB2361243B (en) | 2003-09-03 |
CN1321199A (zh) | 2001-11-07 |
GB9816856D0 (en) | 1998-09-30 |
GB0104403D0 (en) | 2001-04-11 |
DE69921148T2 (de) | 2006-02-16 |
ATE279526T1 (de) | 2004-10-15 |
CN1187453C (zh) | 2005-02-02 |
JP2002526039A (ja) | 2002-08-20 |
KR20010072236A (ko) | 2001-07-31 |
EP1102858A2 (en) | 2001-05-30 |
EP1102858B1 (en) | 2004-10-13 |
IL141127A0 (en) | 2002-02-10 |
US7262033B1 (en) | 2007-08-28 |
BR9912719A (pt) | 2001-05-02 |
AU5183799A (en) | 2000-02-28 |
WO2000008194A2 (en) | 2000-02-17 |
WO2000008194A3 (en) | 2000-05-25 |
AU766267B2 (en) | 2003-10-09 |
GB2361243A (en) | 2001-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6719982B1 (en) | Mutant herpes simplex viruses and uses thereof | |
EP0904395B2 (en) | Herpes simplex virus strains | |
US6613892B2 (en) | HSV viral vector | |
EP0920523B1 (en) | Hsv strain lacking functional icp27 and icp34.5 genes | |
US6319703B1 (en) | Recombinant virus vectors | |
US6261552B1 (en) | Herpes simplex virus vectors | |
US20040063094A1 (en) | Mutant herpes simplex viruses and uses thereof | |
EP1102858B1 (en) | Cell lines for the propagation of mutated herpes viruses | |
AU756892B2 (en) | Mutant herpes simplex viruses and uses thereof | |
Johnson et al. | Replication-defective recombinant herpes simplex virus vectors | |
MXPA01001192A (en) | Cell lines for the propagation of mutated herpes viruses | |
Vos | 5 Herpesviruses as |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |